FAQ

cyclic adenosine-5'-trimetaphosphate

Known as: adenosine-5'-trimetaphosphate, ATMP, Adenosine, 5'-O-(4,6-dihydroxy-1,3,5,2,4,6-trioxatriphosphorinan-2-yl)-, P,P',P''-trioxide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
0102019742017

Related topics

Related topics

1 relation

Broader (1)

Cyclic AMP

Related mentions per year

Related mentions per year

1948-2018
19401960198020002020
cyclic adenosine-5'-trimetaphosphate
Cyclic AMP

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Clinical-scale expansion of mesenchymal stromal cells: a large banking experience
Mesenchymal stromal cells (MSC) are largely investigated in clinical trials aiming to control inappropriate immune reactions… (More)
  • figure 1
  • table 2
  • table 3
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy
According to the European Medicine Agency (EMA) regulatory frameworks, Advanced Therapy Medicinal Products (ATMP) represent a new… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2014
2014
Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks
Abbreviations: GMP: Good Manufacturing Practice; BM: Bone Marrow; HSC: Hematopoietic Stem Cells; MSC: Mesenchymal Stem/Stromal… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 5
Is this relevant?
2013
2013
Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data
Standardization of mesenchymal stromal cells (MSCs) manufacturing is urgently needed to enable translational activities and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2012
2012
Advanced Therapy Medicinal Products and Exemptions to the Regulation 1394/2007: How Confident Can We be? An Exploratory Analysis
The market authorization procedure for medicinal products for human use is relying on their demonstrated efficacy, safety, and… (More)
Is this relevant?
2012
2012
Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development
Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union… (More)
  • table 2
Is this relevant?
2007
2007
Enamel formation in vitro in mouse molar explants exposed to amelogenin polypeptides ATMP and LRAP on enamel development.
OBJECTIVE The enamel matrix contains amelogenin, leucine-rich amelogenin-polypeptide (LRAP), resulting from alternative splicing… (More)
Is this relevant?
2003
2003
Amelogenin interacts with cytokeratin-5 in ameloblasts during enamel growth.
The enamel protein amelogenin binds to GlcNAc (Ravindranath, R. M. H., Moradian-Oldak, R., and Fincham, A.G. (1999) J. Biol. Chem… (More)
Is this relevant?
2002
2002
Environmental risk assessment of phosphonates, used in domestic laundry and cleaning agents in The Netherlands.
In the long-term cooperative project Voluntary Plan of Action (1990) between the Dutch Soap and Detergent Association (NVZ) and… (More)
Is this relevant?
1997
1997
Determination of phosphonates in natural waters by ion-pair high-performance liquid chromatography.
The paper describes a new method for the determination of phosphonates by ion-pair high-performance liquid chromatography. The… (More)
Is this relevant?